Ra Capital Management, L.P. Portfolio Holdings

Ra Capital Management, L.P.

  • $4.82 Billion
  • Q1 2025

Ra Capital Management, L.P. has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $4.82 Billion distributed in 86 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ascendis Pharma A/S with a value of $1.6B, Vaxcyte, Inc. with a value of $460M, Rhythm Pharmaceuticals, Inc. with a value of $322M, Janux Therapeutics, Inc. with a value of $302M, and Arcellx, Inc. with a value of $199M.

Examining the 13F form we can see an decrease of $1.36B in the current position value, from $6.17B to 4.82B.

Ra Capital Management, L.P. is based out at Boston, MA

Below you can find more details about Ra Capital Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $4.82 Billion
Healthcare: $4.82 Billion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$13.2B
$15.3 Million 0.32% of portfolio
200,000
Q2 2024 New

Summary

  • Portfolio
  • No. of Stocks 86
  • Current Value $4.82 Billion
  • Prior Value $6.17 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 11 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email